Hydroxyprogesterone caproate
Hydroxyprogesterone caproate is a man-made progestin hormone. It helps lower the risk of
giving birth too early, which is preterm birth or giving birth less than 37 weeks of pregnancy in
pregnant women. Only pregnant women who are pregnant with one baby and with preterm delivery of one baby in the past have prescribed this medicine.
It is used with mothers who have had a history of gynecological disorders. Hydroxyprogesterone is progestin hormones that reduce the risk of premature birth through a mechanism that is yet to be fully
explained. In combination with other estrogens, it is also used as an injectable form of long
term birth control.
Hydroxyprogesterone caproate is sold under the brand names Proluton and Makena among
others. After the expiry of its original patent, this product has been made and distributed by
companies around the world with ever-newer formulations to increase the conditions it can
help treat.
Schering AG developed OHPC in 1953. It was first reported in the medical literature in 1954.
First marketed only in Japan in 1954 or 1955, it was subsequently introduced as Delalutin in
the United States in 1956. However, the manufacturer Squibb withdrew its patent in 1999,
post which it was also discontinued in the USA. But it was reintroduced in the United States
under the brand name Makena for the treatment of preterm birth in 2011.
Forms and Dosage:
Hydroxyprogesterone caproate is available alone in the form of ampoules and vials of 125
and 250 mg/mL oil solutions for intramuscular injection and a 250 mg/mL autoinjector for use
by subcutaneous injection.
In lowering the risk of Premature Labor, the Usual Adult Dose is given between 16 weeks, 0
days and 20 weeks, 6 days of gestation, is 250 mg, administered intramuscularly once every
7 days in the upper outer quadrant of the gluteus maximus. When the injection is
administered subcutaneously, the usual adult dose is 275 mg once every 7 days in the upper
arm.
The price of Hydroxyprogesterone Caproate
In the USA, consumers have to pay around $2,311.19 for 5ml of 500mg Injection or around
$419 for a supply of 1 milliliter (s). The price of this medicine is significantly cheaper in the
developing or underdeveloped world. For example, the price of 2ml f this medicine costs only
USD 2.5 to USD4. Hydroxyprogesterone Caproate was earlier sold at low prices by
compounding pharmacies in the USA, but this became prohibited in 2016.
How does it work?
Hydroxyprogesterone belongs to a group of drugs called progestin hormones. These work to
reduce the risk of premature birth through a mechanism that is currently not yet fully
understood.
Finding Hydroxyprogesterone Caproate Manufacturers and Suppliers
The best way to find and gain access to Hydroxyprogesterone Caproate manufacturers and
Hydroxyprogesterone Caproate suppliers are to make through Pipelinepharma's global B2B
online marketplace for medicines and other pharmaceuticals.
Normally, finding trusted manufacturers and supplies of specific drugs like
Hydroxyprogesterone Caproate can be a time-consuming challenge, but with
Pipelinepharma's simple search engine and network of proven partners, the whole process
becomes a lot easier.
All you need to do to get started is to make use of our integrated search engine and start
looking for suppliers or manufacturers of Hydroxyprogesterone Caproate to work with. You
can fine-tune your search results using various filters too, letting you search for
Hydroxyprogesterone Caproate from specific countries.
https://en.wikipedia.org/wiki/Hydroxyprogesterone_caproate#:~:text=It%20was%20marketed
%20in%20the,of%20preterm%20birth%20in%202011.
https://www.drugs.com/history/makena.html